期刊文献+

低致敏原应用于特异性免疫治疗的研究进展 被引量:2

The Study on Hypoallergenic Derivatives for Specific Immunotherapy
下载PDF
导出
摘要 过敏性疾病是21世纪重点防治的3大疾病之一,目前仍无有效方法对患者达到治愈的目的.特异性免疫治疗(SIT)是针对过敏性疾病唯一的对因治疗方法,传统的SIT具有很大的副作用,开发低致敏原疫苗将对SIT的安全性方面有着十分重要的意义. Hypersensitivity disease is one of the three key prevention diseases in 21 century. Currently, it has no effective method for radical treatment. Specific immunotherapy is the only way to cure type I hypersensitivity disease thoroughgoingly. However, traditional specific immunotherapy has tremendous side-effects. Therefore, exploitation hypoallergenic derivatives vaccines will play an important role for safer specific immunotherapy.
出处 《江西师范大学学报(自然科学版)》 CAS 北大核心 2011年第4期353-357,共5页 Journal of Jiangxi Normal University(Natural Science Edition)
基金 国家自然科学基金(30871752) 深圳市科技计划三新重点项目(200902) 深圳大学创新团队基金(200904)资助项目
关键词 过敏性疾病 低致敏原 疫苗 特异性免疫治疗(SIT) hypersensiti,,ity disease hypoallergenic vaccine specific immunotherapy(SIT)
  • 相关文献

参考文献47

  • 1Liu Zhigang, Bai Yu, Ji Kunmei, et al. Detection of dermatophagoides farinae in the dust of air conditioning filters [J]. Int Arch Allergy Irnmunol, 2007, 144(1): 85-90.
  • 2Larche M, Akdis C A, Valenta R.lmmunologieal mechanisms of allergen-specific immunotherapy [J]. Nat Rev Immunol, 2006, 6(1): 761-771.
  • 3Ross R N, Nelson H S, Finegold I. Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a metaanalysis [J]. Clin Ther, 2000, 22(3): 351-358.
  • 4Ross R N, Nelson H S, Finegold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized prospective, single or double-blind, placebocontrolled studies [J]. Clin Ther, 2000, 22(3): 342-350.
  • 5Pipet A, Botturi K, Pinot D, et al. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy [J]. Respir Med, 2009, 103(6): 800-812.
  • 6Akbari O, DcKruyff R H, Umetsu D T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen [J]. Nat Immunol, 2001, 2(8): 725-731.
  • 7Nouri-Aria K T, Wachholz P A, Francis J N, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity [J]. J Immunol, 2004, 172(5): 3252-3259.
  • 8Gafvelin G, Thunberg S, Kronqvist M, et al. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1 [J]. Int Arch Allergy Immunol, 2005, 138(1): 59-66.
  • 9Akdis C A, Joss A, Akdis M, et al. A molecular basis for T cell suppression by IL-10:CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding [J]. FASEB J, 2000, 14(12): 1666-1668.
  • 10Gardner L M, Thien F C, Douglass J A, et al. Induction of T "regulatory" cells by standardized house dust mite immunotherapy: an increase in CD4+CD25+interleukin-10+T cells expressing peripheral tissue trafficking markers [J]. Clin Exp Allergy, 2004, 34(8): 1209-1219.

二级参考文献53

共引文献24

同被引文献39

  • 1孟光,李春林,蔡琼香,谢春梅.海口地区热带植物花粉致敏性调查[J].临床耳鼻咽喉科杂志,2005,19(22):1044-1045. 被引量:27
  • 2Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients studies [J]. JAMA, 1998, 279 a meta-analysis of prospective (15): 1200-1205.
  • 3Warrington R, Silviu-Dan F. Drug allergy [J]. Allergy Asth- ma Clin Immunol, 2011, 7 (Suppl 1): S10.
  • 4Leone R, Conforti A, Venegoni M, et al. Drug-induced ana- phylaxis: case/non-ease study based on an Italian pharmaco- vigilance database [J]. Drug Saf, 2005, 28 (6): 547-556.
  • 5Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions [J]. Clin Exp Allergy, 2000, 30 (8): 1144-1150.
  • 6Mirakian R, Ewan PW, Durham SR, et al. BSACI guidelines for the management of drug allergy [J]. Clin Exp Allergy, 2010, 40 (5): 697-699.
  • 7Weiss WE, Adkinson NF. Immediate hypersensitivity reac- tions to penicillin and related antibiotics [J]. Clin Allergy, 1988, 18 (6): 515-540.
  • 8Soyer OU, Akdis M, Akdis CA. Mechanisms of subcutane- ous allergen immunotherapy [ J ]. Immunol Allergy Clin North Am, 2011, 31 (2): 175-190.
  • 9Bruschi F, Pozio E, Watanabe N, et al. Anaphylactic re- sponse to parasite antigens: IgE and IgG1 independently in- duce death in Trichinella-infected mice [J]. Int Arch Allergy Immunol, 1999, 119 (4): 291-296.
  • 10Knol EF. Requirements for effective IgE cross-linking on mast cells and basophils [J]. Mol Nutr Food Res, 2006, 50 (7): 620-624.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部